Literature DB >> 19919606

Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients.

Øivind Torkildsen1, Christine Stansberg, Solveig M Angelskår, Evert-Jan Kooi, Jeroen J G Geurts, Paul van der Valk, Kjell-Morten Myhr, Vidar M Steen, Lars Bø.   

Abstract

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). Microarray-based global gene expression profiling is a promising method, used to study potential genes involved in the pathogenesis of the disease. In the present study, we have examined global gene expression in normal-appearing gray matter and gray matter lesions from the cortex of MS patients, and compared them with cortical gray matter samples from controls. We observed a massive upregulation of immunoglobulin (Ig)-related genes in cortical sections of MS patients. Using immunohistochemistry, the activation of Ig genes seems to occur within plasma cells in the meninges. As synthesis of oligoclonal IgGs has been hypothesized to be caused by the activation of Epstein-Barr virus (EBV)-infected B-cells, we screened the brain samples for the presence of EBV by real-time quantitative polymerase chain reaction (qPCR) and immunohistochemistry, but no evidence of active or latent EBV infection was detected. This study demonstrates that genes involved in the synthesis of Igs are upregulated in MS patients and that this activation is caused by a small number of meningeal plasma cells that are not infected by EBV. The findings indicate that the Ig-producing B-cells found in the cerebrospinal fluid (CSF) of MS patients could have meningeal origin.

Entities:  

Mesh:

Year:  2009        PMID: 19919606     DOI: 10.1111/j.1750-3639.2009.00343.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  31 in total

Review 1.  Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.

Authors:  Ranjan Dutta
Journal:  Mult Scler       Date:  2013-09       Impact factor: 6.312

Review 2.  Cortical lesions in multiple sclerosis.

Authors:  Massimiliano Calabrese; Massimo Filippi; Paolo Gallo
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

3.  No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis.

Authors:  Mehrnaz Ighani; Samuel Jonas; Izlem Izbudak; Seongjin Choi; Alfonso Lema-Dopico; Jun Hua; Erin E O'Connor; Daniel M Harrison
Journal:  Mult Scler       Date:  2019-10-01       Impact factor: 6.312

Review 4.  Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.

Authors:  Gregory P Owens; Jeffrey L Bennett
Journal:  Mult Scler       Date:  2012-06-08       Impact factor: 6.312

Review 5.  Grey matter damage in multiple sclerosis: a pathology perspective.

Authors:  Roel Klaver; Helga E De Vries; Geert J Schenk; Jeroen J G Geurts
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

6.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

7.  Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus.

Authors:  Maria T Cencioni; Roberta Magliozzi; Richard Nicholas; Rehiana Ali; Omar Malik; Richard Reynolds; Giovanna Borsellino; Luca Battistini; Paolo A Muraro
Journal:  Immunology       Date:  2017-09-21       Impact factor: 7.397

Review 8.  The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.

Authors:  Giulia Mallucci; Luca Peruzzotti-Jametti; Joshua D Bernstock; Stefano Pluchino
Journal:  Prog Neurobiol       Date:  2015-03-21       Impact factor: 11.685

Review 9.  The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.

Authors:  Caterina Veroni; Francesca Aloisi
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

10.  Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.

Authors:  Daniela F Angelini; Barbara Serafini; Eleonora Piras; Martina Severa; Eliana M Coccia; Barbara Rosicarelli; Serena Ruggieri; Claudio Gasperini; Fabio Buttari; Diego Centonze; Rosella Mechelli; Marco Salvetti; Giovanna Borsellino; Francesca Aloisi; Luca Battistini
Journal:  PLoS Pathog       Date:  2013-04-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.